首页> 外文期刊>Obstetrics and Gynecology International >First Trimester Aneuploidy Screening Program for Preeclampsia Prediction in a Portuguese Obstetric Population
【24h】

First Trimester Aneuploidy Screening Program for Preeclampsia Prediction in a Portuguese Obstetric Population

机译:葡萄牙产科人群子痫前期预测的第一个三个月非整倍体筛选程序

获取原文
           

摘要

Objective. To evaluate the performance of a first trimester aneuploidy screening program for preeclampsia (PE) prediction in a Portuguese obstetric population, when performed under routine clinical conditions.Materials and Methods. Retrospective cohort study of 5672 pregnant women who underwent routine first trimester aneuploidy screening in a Portuguese university hospital from January 2009 to June 2013. Logistic regression-based predictive models were developed for prediction of PE based on maternal characteristics, crown-rump length (CRL), nuchal translucency thickness (NT), and maternal serum levels of pregnancy-associated plasma protein-A (PAPP-A) and free beta-subunit of human chorionic gonadotropin (freeβ-hCG).Results. At a false-positive rate of 5/10%, the detection rate for early-onset (EO-PE) and late-onset (LO-PE) PE was 31.4/45.7% and 29.5/35.2%, respectively. Although both forms of PE were associated with decreased PAPP-A, logistic regression analysis revealed significant contributions from maternal factors, freeβ-hCG, CRL, and NT, but not PAPP-A, for prediction of PE.Conclusion. Our findings support that both clinical forms of EO-PE and LO-PE can be predicted using a combination of maternal history and biomarkers assessed at first trimester aneuploidy screening. However, detection rates were modest, suggesting that models need to be improved with additional markers not included in the current aneuploidy screening programs.
机译:目的。若要评估在常规临床条件下进行的葡萄牙产科人群中子痫前期(PE)预测的早孕非整倍性筛查程序的性能,材料和方法。对2009年1月至2013年6月在葡萄牙大学医院接受常规早孕非整倍性筛查的5672名孕妇进行的回顾性队列研究。开发了基于Logistic回归的预测模型,基于孕妇特征,冠臀长(CRL)预测PE ,与孕妇绒毛膜促性腺激素相关的血浆蛋白A(PAPP-A)和游离β亚基(游离β-hCG)的母体半透明厚度(NT)和母体血清水平。在5/10%的假阳性率下,早期发作(EO-PE)和晚期发作(LO-PE)PE的检出率分别为31.4 / 45.7%和29.5 / 35.2%。尽管两种形式的PE均与PAPP-A降低有关,但Logistic回归分析显示,母亲因素,游离β-hCG,CRL和NT的贡献很大,而PAPP-A却无显着贡献。我们的发现支持EO-PE和LO-PE的两种临床形式都可以结合孕妇的病史和在孕早期非整倍性筛查中评估的生物标志物进行预测。但是,检测率不高,表明需要使用当前非整倍性筛选程序中未包含的其他标记物来改进模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号